XBiotech Management
Management criteria checks 2/4
XBiotech's CEO is John Simard, appointed in Mar 2005, has a tenure of 19.67 years. total yearly compensation is $5.56M, comprised of 19.2% salary and 80.8% bonuses, including company stock and options. directly owns 12.54% of the company’s shares, worth $26.23M. The average tenure of the management team and the board of directors is 7 years and 7.6 years respectively.
Key information
John Simard
Chief executive officer
US$5.6m
Total compensation
| CEO salary percentage | 19.2% |
| CEO tenure | 19.7yrs |
| CEO ownership | 12.5% |
| Management average tenure | 7yrs |
| Board average tenure | 7.6yrs |
Recent management updates
Recent updates
Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load?
Aug 30
XBiotech: Several Shots On Goal In Big Target Market Indications
May 24Is XBiotech (NASDAQ:XBIT) Using Debt In A Risky Way?
May 13We're Not Very Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Rate
Feb 09We're Hopeful That XBiotech (NASDAQ:XBIT) Will Use Its Cash Wisely
Oct 25We Think Some Shareholders May Hesitate To Increase XBiotech Inc.'s (NASDAQ:XBIT) CEO Compensation
Jun 16XBiotech (NASDAQ:XBIT) Is In A Good Position To Deliver On Growth Plans
May 11Read This Before Buying XBiotech Inc. (NASDAQ:XBIT) Shares
Mar 18Here's Why We Don't Think XBiotech's (NASDAQ:XBIT) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 08XBiotech's influenza-COVID-19 therapeutic cocktail shows effective anti-virus activity
Nov 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$33m |
| Jun 30 2024 | n/a | n/a | -US$35m |
| Mar 31 2024 | n/a | n/a | -US$31m |
| Dec 31 2023 | US$6m | US$1m | -US$25m |
| Sep 30 2023 | n/a | n/a | -US$23m |
| Jun 30 2023 | n/a | n/a | -US$28m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$5m | US$881k | -US$33m |
| Sep 30 2022 | n/a | n/a | -US$36m |
| Jun 30 2022 | n/a | n/a | -US$27m |
| Mar 31 2022 | n/a | n/a | -US$20m |
| Dec 31 2021 | US$8m | US$777k | -US$17m |
| Sep 30 2021 | n/a | n/a | -US$13m |
| Jun 30 2021 | n/a | n/a | -US$12m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$3m | US$684k | -US$11m |
| Sep 30 2020 | n/a | n/a | US$677m |
| Jun 30 2020 | n/a | n/a | US$673m |
| Mar 31 2020 | n/a | n/a | US$674m |
| Dec 31 2019 | US$11m | US$591k | US$669m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$23m |
| Mar 31 2019 | n/a | n/a | -US$23m |
| Dec 31 2018 | US$1m | US$585k | -US$21m |
| Sep 30 2018 | n/a | n/a | -US$22m |
| Jun 30 2018 | n/a | n/a | -US$23m |
| Mar 31 2018 | n/a | n/a | -US$27m |
| Dec 31 2017 | US$702k | US$566k | -US$33m |
Compensation vs Market: John's total compensation ($USD5.56M) is above average for companies of similar size in the US market ($USD1.48M).
Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.
CEO
John Simard (62 yo)
19.7yrs
Tenure
US$5,556,481
Compensation
Mr. John Simard is the Founder of XBiotech, Inc. and serves as its Chairman and has been its Chief Executive Officer and President since March 2005. Mr. Simard serves as the Chairman, Chief Executive Offic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 19.7yrs | US$5.56m | 12.54% $ 26.2m | |
| Director of Finance | 1.8yrs | US$279.29k | 0.084% $ 174.9k | |
| Chief Scientific Officer | 7yrs | US$720.50k | 0% $ 0 |
7.0yrs
Average Tenure
46yo
Average Age
Experienced Management: XBIT's management team is seasoned and experienced (7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 19.7yrs | US$5.56m | 12.54% $ 26.2m | |
| Independent Director | 15.8yrs | US$190.94k | 8.65% $ 18.1m | |
| Independent Director | 6.7yrs | US$187.94k | 0.033% $ 68.6k | |
| Member of Scientific Advisory Board & Independent Director | 6.2yrs | US$163.94k | 0.082% $ 171.5k | |
| Member of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Lead Independent Director | 6.8yrs | US$196.94k | 0.66% $ 1.4m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
7.6yrs
Average Tenure
75yo
Average Age
Experienced Board: XBIT's board of directors are considered experienced (7.6 years average tenure).